https://www.selleckchem.com/products/reversan.html
Overall, AEs were reported by 35.3% of participants aged2years and 45% of participants aged 2-55years. Solicited adverse reactions were reported by 21.4% and 17.4% of participants aged2years and 2-55years, respectively. Unsolicited adverse reactions were reported by 26.1% and 37.9%, respectively. No vaccine-related SAEs occurred during the study. The AEs reported in Korean population were consistent with the known safety profile of MenACWY-DT, and most were of grade 1-2 in severity. This study did not detect any unanticipated o
Like
Comment
Share
